Thanks to private funding, 100% of every dollar donated to The Lustgarten Foundation goes directly to pancreatic cancer research.

Research Awards Listing

Research follows dollars, and The Lustgarten Foundation believes that increasing funds for pancreatic cancer research will translate into enhanced patient care, and ultimately, a cure.

The Lustgarten Foundation firmly believes that increasing funds for pancreatic cancer research is the surest path to improved patient care and eventually, to a cure. To date, we have committed more than $120 million to providing the best and brightest minds with the resources to pursue the study and eradication of the disease.

View Award Listings by Year

2015 | 2014 |  2013  |  2012  |  2011  |  2010  | 2009  |  2008  | 2007  |  2006  |  2005  |  2004  |  2003  |  2002  |  2001  |  2000-1998

2006 Research Grants

David Frank, M.D., Ph.D.
Inhibition of STAT3 in the Targeted Therapy of Pancreatic Cancer
Dana-Farber Cancer Institute

Marcia Canto, M.D.
Screening for Early Pancreatic Neoplasia: A Multicenter Study
Johns Hopkins University

James Eshleman, M.D., Ph.D.
Pancreatic Cancer Tumor Suppressor Gene Discovery using RNAi
Johns Hopkins University 

Elizabeth Jaffee, M.D.
Identification and Analysis of New Pancreatic Antigens as Targets of the Immune Response
Johns Hopkins University 

Anirban Maitra, MBBS
Synergistic Targeting of the Apoptotic Machinery in Pancreatic Cancer
Johns Hopkins University

Bert Vogelstein, M.D.
Sequencing the Pancreatic Cancer Genome
Johns Hopkins University

David Konieczny, Ph.D.
Mist 1 Kras G12D Generated Pancreatic Cancer
Purdue University 

Inder M. Verma, Ph.D.
A Novel Mouse Model of Pancreatic Cancer Using Lentiviral Vectors
Salk Institute for Biological Studies 

Steven Gallinger, M.D.
Characterization of Germline DNA Copy Number Variation in Familial Pancreas Cancer
Lunenfeld-Tanenbaum Research Institute

Martin McMahon, Ph.D.
Targeting Kinases to Overcome Gemcitabine Resistance in Pancreatic Carcinoma
University of California, San Francisco 

George Halder, Ph.D.
A Novel Genetic System to Identify Ideal Cancer Drug Targets in Pancreatic Cancer
University of Texas M.D. Anderson Cancer Center

415 Crossways Park Drive, Suite D, Woodbury, NY 11797
Toll Free: 1-866-789-1000 P: 516-737-1550 F: 516-584-6265


2015 website development and design sponsored by Celgene